The role of the endocannabinoid system in liver diseases.

@article{Caraceni2009TheRO,
  title={The role of the endocannabinoid system in liver diseases.},
  author={Paolo Caraceni and Marco Domenicali and Ferdinando Antonino Giannone and Mauro Bernardi},
  journal={Best practice & research. Clinical endocrinology & metabolism},
  year={2009},
  volume={23 1},
  pages={
          65-77
        }
}
Endogenous cannabinoids (ECs) are ubiquitous lipid signaling molecules provided by a number of central and peripheral effects, which are mediated mainly by the specific receptors CB1 and CB2. In the last decade a considerable number of studies has shown that ECs and their receptors play an important role in the pathophysiology of liver diseases. The EC system is strongly up-regulated during chronic liver diseases. Until now it has been implicated in the pathogenesis of fatty liver disease… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 23 CITATIONS

Cannabinoid receptor 1 knockout alleviates hepatic steatosis by downregulating perilipin 2

  • Laboratory Investigation
  • 2019
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Marijuana use in hepatitis C infection does not affect liver biopsy histology or treatment outcomes.

  • Canadian journal of gastroenterology & hepatology
  • 2014
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 67 REFERENCES

Endocannabinoids in the pathogenesis and treatment of liver fibrosis

SV Siegmund, RF Shwabe
  • American Journal of Physiology Gastrointestinal and Liver Physiology
  • 2008